SubscribeLatest 5 articles from heartwire
- Interventional cardiologist Donald Baim dies
Nov 06, 2009 18:22 EDT - Latest European and US STEMI guidelines compared and contrasted
Nov 06, 2009 17:15 EDT - Enrollment halts in randomized trial of CPR for out-of-hospital arrest
Nov 06, 2009 16:00 EDT - Medicaid access to smoking cessation falls short
Nov 05, 2009 17:30 EDT - Serum phosphorous, kidney function predict CAC
Nov 05, 2009 17:00 EDT
Featured ProgramsProgrammes de formation médicale
Episode #10: Comparative effectiveness with Dr Harlan Krumholz
Please note that the audio will stop and restart at the beginning of the file when submitting a comment.
Veuillez notez que le fichier audio s’arrête et recommence au début lorsqu’un commentaire est publié.
DOWNLOAD
Download this episode in your preferred format:
Clinicians, politicians, policy makers and payers are talking about comparative effectiveness with catch phrases as varied as "focusing on what works," "rationing care," and "limiting choices". But what does "comparative effectiveness" really mean? To help answer this question and unravel the implications for practitioners, cardiovascular research and patient care, Dr Harlan Krumholz joins the show with thoughts and expertise to tackle this controversial and timely issue.
What are your thoughts? Join in by commenting below or calling 1-866-996-5440 to leave an audio response.
Previous postsBillets précédents
Also from theheart.org
About The Bob Harrington Show
Take part in this new interactive series! Start by joining Dr Harrington and his guests for a frank and insightful review of the latest clinical trials, events and education in the realm of cardiology. Then it’s your turn: share your thoughts by writing them in the comments box (at left) or by phoning our studios and leaving a voice message: 1-866-996-5440. There’s a show posted every two weeks, why not join in? We value the diverse opinions of our readership — that includes you — and look forward to a hearty exchange!
About Dr Robert A Harrington
Dr Robert A Harrington is a Professor of Medicine at Duke University, Director of the Duke Clinical Research Institute, and a practicing interventional cardiologist. He is the recipient of an NIH Roadmap contract to investigate “best practices” among clinical trial networks, and is a Fellow of the ACC, AHA, SCAI, and American College of Chest Physicians. In addition, he currently serves as a member of the FDA Cardiovascular and Renal Drugs Advisory Committee and is a member of the NHLBI’s study section for clinical trials. A member of the ACC’s Board of Trustees, Dr Harrington chaired the ACC 2006 Annual Scientific Sessions.
CommentsCommentaires